Overheard: Experts give advice for Houston startups looking for corporate partnerships

Eavesdropping in Houston

Good things don't just come to those who wait. If you're wanting to get your startup in front of major corporations, you need to take matters into your own hands. Pexels

If you've ever wanted to know the best way to get your startup in front of a major corporation, according to experts from both sides of the table — here's your chance.

At the Houston Innovation Open Conference, five major players in Houston's innovation ecosystem sat on a panel and discussed startups, accelerators, and more. One question asked each panelist for their advice for corporate partnerships. Here's what they had to say.

“Go to one of our programs — even if you used to work at an oil and gas company, as a startup, you need new pathways and you need help and support and lots of love along the way.”

— Gabriella Rowe, CEO of Station Houston. Even with a Houston business background, there's strength in numbers, she says.

“Keep your identity along the way.”

— Haibin Xu, regional manager of Shell Research Connect & GameChanger US and Canada. From the corporate side of things. Xu said sometimes the Shells of the world can't help you — find the right company that best aligns with your startup.

“Do your research. … And have a clear value proposition, and put it on the table.”

— Wade Bitaraf, head of energy and sustainability practice at Plug and Play. Preparation and research is extremely important before you meet with any potential corporate partners.

“Find a community to join … and don’t limit yourself to what you think is your industry.”

— Brad True, managing director of The Cannon and Cannon Ventures. True gave an example of a Cannon company that found success outside the industry they thought they were confined to.

“You have to find the pathways that are going to make it as easy as possible.”

— Brian Richards, innovation lead and managing director at Accenture. Richards emphasized that startups can go bankrupt waiting for something formal from a big corporation.

Speakers at the third annual Houston Innovation Open Conference discussed policy, performance, and more. Photo by Zview/Getty Images

Overheard: 5 powerful quotes from Houstonians speaking at the Houston Open Innovation Conference

EAVESDROPPING IN Houston

When it comes to Houston's innovation ecosystem, there's a lot to discuss. From accelerator programs to role of educational institutes, the third annual Houston Open Innovation Conference covered it all on Thursday, March 28.

I had the pleasure of attending the full-day conference, which was a meeting of the minds of Houston innovation. To catch you up and rid you of your fear of missing out, check out these five overheard quotes from the day.

“I’ve charged my board on Houston Exponential, and I say to them, ‘What good is it for us to be the most diverse city in the country if we’re not solving the challenges that impact diverse communities.’”

— Amanda Edwards, Houston City Council Member in At-Large Position 4, in her keynote presentation calling for Houston to lead the charge in solving inequalities in innovation.

“Competition is good. I would rather have an abundance of an ecosystem than just one (accelerator). I think each different group — whether it’s MassChallenge, Station Houston, or The Cannon or any other current or future accelerator — all has their own value proposition.”

— Brian Richards, managing director, Accenture Houston Innovation Hub, during the panel about startups and entrepreneurs. The quote was in response to an audience question about competition within Houston accelerators and programs.

“If we don’t create this ecosystem, others will tap into the resources we have, and we lose or we fall short.”

— Mayor Sylvester Turner, in his keynote presentation, explaining why the city is focused on developing the city's ecosystem now — before it's too late.

“I think the more emphasis on incubators and accelerators has addressed the need for community. You have people who are like minded … and you have a community that cares about something more deep rather than just being in the same physical space together.”

— Grace Rodriguez, CEO and executive director of Impact Hub Houston, on the panel about accelerators and incubators. The panel question was regarding how some coworking spaces have evolved to be accelerator or incubator programs.

“This is such a uniquely positioned city because of its corporate base, because of the strength of its university structure, and because of the combination of that and the ability to collaborate within those two is a different kind of runway or opportunity.”

— Susan Davenport, senior vice president, economic development at the Greater Houston Partnership, during the "Houston Innovation Ecosystem" panel.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”

View All Listings